• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2013年至2023年肺癌患者报告结局的可视化分析

A Visual Analysis of Patient-Reported Outcomes in Lung Cancer From 2013 to 2023.

作者信息

Gu Zhirong, Wu Liu, Li Jinxing, Zheng Silin, Huang Min

机构信息

School of Nursing, Southwest Medical University, Luzhou, China.

Department of Nursing, Affiliated Hospital of Southwest Medical University, Luzhou, China.

出版信息

Cancer Control. 2024 Jan-Dec;31:10732748241266490. doi: 10.1177/10732748241266490.

DOI:10.1177/10732748241266490
PMID:39115094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11311154/
Abstract

BACKGROUND

Lung cancer is the most common cancer in the world and has become one of the malignancies with the highest incidence and mortality; more than half of patients die within one year of being diagnosed with lung cancer. In recent years, the concept of "patient-centered" service has gained popularity, and patients' subjective feelings have gradually been used in clinical decision-making. Therefore, this study determined the application of visual patient report outcomes in the field of lung cancer, in order to provide reference for specific clinical practice.

METHODS

Using the Web of Science core collection as the main analysis content, Citespace and VOSviewer were used to conduct this scientometric study.

RESULTS

A total of 499 literatures that met the inclusion criteria were retrieved. The most prolific institution was The University of Texas MD Anderson Cancer Center, and the United States dominates this field.

CONCLUSION

The measurement of patient-reported outcomes is considered the gold standard for effectively evaluating patients' perceptions of clinical interventions or diseases. It is recommended that patient-reported outcomes be integrated into routine care for cancer patients in order to enhance communication between patients and healthcare providers.

PATIENT OR PUBLIC CONTRIBUTION

Not applicable. All data in this paper are obtained from the web of science database.

摘要

背景

肺癌是全球最常见的癌症,已成为发病率和死亡率最高的恶性肿瘤之一;超过一半的肺癌患者在确诊后一年内死亡。近年来,“以患者为中心”的服务理念日益普及,患者的主观感受逐渐被应用于临床决策。因此,本研究确定视觉患者报告结局在肺癌领域的应用情况,以便为具体临床实践提供参考。

方法

以科学网核心合集作为主要分析内容,使用Citespace和VOSviewer进行这项科学计量学研究。

结果

共检索到499篇符合纳入标准的文献。发文量最多的机构是德克萨斯大学MD安德森癌症中心,美国在该领域占据主导地位。

结论

患者报告结局的测量被认为是有效评估患者对临床干预或疾病认知的金标准。建议将患者报告结局纳入癌症患者的常规护理中,以加强患者与医疗服务提供者之间的沟通。

患者或公众贡献

不适用。本文所有数据均来自科学网数据库。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/d15a635b88ef/10.1177_10732748241266490-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/6177049e4fbf/10.1177_10732748241266490-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/637bdd35ac61/10.1177_10732748241266490-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/605bb619ec83/10.1177_10732748241266490-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/9e1378bd860a/10.1177_10732748241266490-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/a676cd4f728b/10.1177_10732748241266490-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/47a12bc5cf67/10.1177_10732748241266490-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/0d6e2dd1229a/10.1177_10732748241266490-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/66ce91097edb/10.1177_10732748241266490-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/38c1dc378166/10.1177_10732748241266490-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/d15a635b88ef/10.1177_10732748241266490-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/6177049e4fbf/10.1177_10732748241266490-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/637bdd35ac61/10.1177_10732748241266490-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/605bb619ec83/10.1177_10732748241266490-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/9e1378bd860a/10.1177_10732748241266490-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/a676cd4f728b/10.1177_10732748241266490-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/47a12bc5cf67/10.1177_10732748241266490-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/0d6e2dd1229a/10.1177_10732748241266490-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/66ce91097edb/10.1177_10732748241266490-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/38c1dc378166/10.1177_10732748241266490-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6d/11311154/d15a635b88ef/10.1177_10732748241266490-fig10.jpg

相似文献

1
A Visual Analysis of Patient-Reported Outcomes in Lung Cancer From 2013 to 2023.2013年至2023年肺癌患者报告结局的可视化分析
Cancer Control. 2024 Jan-Dec;31:10732748241266490. doi: 10.1177/10732748241266490.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Association of Actual and Preferred Decision Roles With Patient-Reported Quality of Care: Shared Decision Making in Cancer Care.实际和期望的决策角色与患者报告的护理质量的关联:癌症护理中的共同决策。
JAMA Oncol. 2015 Apr;1(1):50-8. doi: 10.1001/jamaoncol.2014.112.
4
Bibliometric and visual analysis of photodynamic therapy for lung cancer from 2010 to 2022.2010年至2022年肺癌光动力治疗的文献计量学与可视化分析
Transl Cancer Res. 2024 Feb 29;13(2):738-751. doi: 10.21037/tcr-23-1238. Epub 2024 Feb 23.
5
A bibliometric and visual analysis of cancer-associated fibroblasts.癌症相关成纤维细胞的文献计量学和可视化分析。
Front Immunol. 2023 Dec 19;14:1323115. doi: 10.3389/fimmu.2023.1323115. eCollection 2023.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
A worldwide bibliometric analysis of acromegaly in the past two decades: 1999-2022.过去二十年(1999 - 2022年)全球肢端肥大症的文献计量分析
Front Neurosci. 2023 Jul 5;17:1187820. doi: 10.3389/fnins.2023.1187820. eCollection 2023.
8
The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.医院环境中患者与护士以患者为中心的沟通体验:一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):76-87. doi: 10.11124/jbisrir-2015-1072.
9
Global research trends on immunotherapy in cancer: A bibliometric analysis.全球癌症免疫治疗研究趋势:文献计量分析。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2219191. doi: 10.1080/21645515.2023.2219191.
10
Global research trends between gut microbiota and lung cancer from 2011 to 2022: A bibliometric and visualization analysis.2011年至2022年肠道微生物群与肺癌的全球研究趋势:文献计量与可视化分析
Front Oncol. 2023 Feb 23;13:1137576. doi: 10.3389/fonc.2023.1137576. eCollection 2023.

本文引用的文献

1
The h-Index: Understanding its predictors, significance, and criticism.h指数:了解其预测因素、意义及批评意见。
J Family Med Prim Care. 2023 Nov;12(11):2531-2537. doi: 10.4103/jfmpc.jfmpc_1613_23. Epub 2023 Nov 21.
2
Assessing Patient-Reported Outcomes in Routine Cancer Clinical Care Using Electronic Administration and Telehealth Technologies: Realist Synthesis of Potential Mechanisms for Improving Health Outcomes.使用电子管理和远程医疗技术在常规癌症临床护理中评估患者报告的结果:改善健康结果的潜在机制的实际综合分析。
J Med Internet Res. 2023 Nov 28;25:e48483. doi: 10.2196/48483.
3
Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON).
度伐利尤单抗联合或不联合 Tremelimumab 加化疗作为转移性非小细胞肺癌一线治疗的患者报告结局(POSEIDON)。
Lung Cancer. 2023 Dec;186:107422. doi: 10.1016/j.lungcan.2023.107422. Epub 2023 Nov 11.
4
Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC.KEYNOTE-604研究中患者报告的与健康相关的生活质量:帕博利珠单抗或安慰剂联合依托泊苷和铂类作为广泛期小细胞肺癌的一线治疗
JTO Clin Res Rep. 2023 Sep 9;4(11):100572. doi: 10.1016/j.jtocrr.2023.100572. eCollection 2023 Nov.
5
Real-world impact of patient-reported outcome measurement on overall survival, healthcare use and treatment discontinuation in cancer patients.患者报告结局测量对癌症患者总生存期、医疗保健使用和治疗中断的真实世界影响。
J Comp Eff Res. 2023 Oct;12(10):e230061. doi: 10.57264/cer-2023-0061. Epub 2023 Aug 9.
6
Evaluating and improving real-world evidence with Targeted Learning.基于靶向学习评估和改进真实世界证据。
BMC Med Res Methodol. 2023 Aug 2;23(1):178. doi: 10.1186/s12874-023-01998-2.
7
Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis.新辅助免疫治疗的演化模式与研究前沿:文献计量分析。
Int J Surg. 2023 Sep 1;109(9):2774-2783. doi: 10.1097/JS9.0000000000000492.
8
Experience With the Routine Use of Electronic Patient-Reported Outcome Measures for Patients With Lung Cancer.肺癌患者常规使用电子患者报告结局测量的经验。
JCO Clin Cancer Inform. 2023 Apr;7:e2200150. doi: 10.1200/CCI.22.00150.
9
Improving the Understanding and Managing of the Quality of Life of Patients With Lung Cancer With Electronic Patient-Reported Outcome Measures: Scoping Review.利用电子患者报告结局测量工具提高肺癌患者对生活质量的理解和管理:范围综述。
J Med Internet Res. 2023 May 3;25:e46259. doi: 10.2196/46259.
10
Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study.利用患者来源的类器官预测局部晚期或转移性肺癌肿瘤的反应:一项真实世界的研究。
Cell Rep Med. 2023 Feb 21;4(2):100911. doi: 10.1016/j.xcrm.2022.100911. Epub 2023 Jan 18.